Immuno-histochemical analysis of rod and cone reaction to RPE65 deficiency in the inferior and superior canine retina

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Klein, Daniela ^a   Mendes Madeira, Alexandra ^b   Schlegel, Patrice ^c   Rolling, Fabienne ^b   Lorenz, Birgit ^a   Haverkamp, Silke ^d   Stieger, Knut ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b INSERM   (France)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONE OPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ACTIVITY; DOG; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PIGMENT EPITHELIUM; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA CONE; RETINA DISEASE; RETINA ROD; RETINAL PIGMENT EPITHELIUM 65 GENE; SYNAPTIC MEMBRANE;

ANIMALS; CIS-TRANS-ISOMERASES; CONE OPSINS; DOGS; GENETIC THERAPY; IMMUNOHISTOCHEMISTRY; RETINA; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL ROD PHOTORECEPTOR CELLS; ROD OPSINS;

EID: 84907033636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086304     Document Type: Article

References (49)

1. Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma J-X (2005) RPE65 is the isomerohydrolase in the retinoid visual cycle. Proceedings of the National Academy of Sciences of the United States of America 102: 12413-12418. doi:10.1073/pnas.0503460102. (Pubitemid 41266373)
2. Jin M, Li S, Moghrabi WN, Sun H, Travis GH (2005) Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 122: 449-459. doi:10.1016/j.cell.2005.06.042. (Pubitemid 41127145)
3. Tang PH, Buhusi MC, Ma J-X, Crouch RK (2011) RPE65 is present in human green/red cones and promotes photopigment regeneration in an in vitro cone cell model. The Journal of neuroscience: the official journal of the Society for Neuroscience 31: 18618-18626. doi:10.1523/JNEUROSCI.4265-11.2011.
4. Tang PH, Wheless L, Crouch RK (2011) Regeneration of photopigment is enhanced in mouse cone photoreceptors expressing RPE65 protein. The Journal of neuroscience: the official journal of the Society for Neuroscience 31: 10403-10411. doi:10.1523/JNEUROSCI.0182-11.2011.
5. Takahashi Y, Moiseyev G, Chen Y, Nikolaeva O, Ma J-X (2011) An alternative isomerohydrolase in the retinal Müller cells of a cone-dominant species. The FEBS journal 278: 2913-2926. doi:10.1111/j.1742-4658.2011.08216.x.
6. Wang J-S, Kefalov VJ (2009) An alternative pathway mediates the mouse and human cone visual cycle. Current biology: CB 19: 1665-1669. doi:10.1016/j.cub.2009.07.054.
7. Wang J-S, Kefalov VJ (2011) The cone-specific visual cycle. Progress in retinal and eye research 30: 115-128. doi:10.1016/j.preteyeres.2010.11.001.
8. Kaylor JJ, Yuan Q, Cook J, Sarfare S, Makshanoff J, et al. (2013) Identification of DES1 as a vitamin A isomerase in Müller glial cells of the retina. Nature chemical biology 9: 30-36. doi:10.1038/nchembio.1114.
9. Lorenz B, Gyürüs P, Preising M, Bremser D, Gu S, et al. (2000) Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. Investigative Ophthalmology & Visual Science 41: 2735-2742. (Pubitemid 30624407)
10. Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, et al. (2004) Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology Aug 111: 1585-1594. doi:10.1016/j.ophtha.2004.01.033.
11. Lorenz B, Poliakov E, Schambeck M, Friedburg C, Preising MN, et al. (2008) A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation. Investigative ophthalmology & visual science 49: 5235-5242. doi:10.1167/iovs.07-1671.
12. Jacobson SG, Aleman TS, Cideciyan AV, Roman AJ, Sumaroka A, et al. (2009) Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. Investigative ophthalmology & visual science 50: 2368-2375. doi:10.1167/iovs.08-2696.
13. Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Windsor EAM, et al. (2008) Photoreceptor layer topography in children with leber congenital amaurosis caused by RPE65 mutations. Investigative ophthalmology & visual science 49: 4573-4577. doi:10.1167/iovs.08-2121.
14. Lorenz B, Strohmayr E, Zahn S, Friedburg C, Kramer M, et al. (2012) Chromatic pupillometry dissects function of the three different light-sensitive retinal cell populations in RPE65 deficiency. Investigative ophthalmology & visual science 53: 5641-5652. doi:10.1167/iovs.12-9974.
15. Redmond TM, Yu S, Lee E, Bok D, Hamasaki D, et al. (1998) Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nature genetics 20: 344-351. doi:10.1038/3813. (Pubitemid 28541631)
16. Samardzija M, von Lintig J, Tanimoto N, Oberhauser V, Thiersch M, et al. (2008) R91W mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal. Human molecular genetics 17: 281-292. doi:10.1093/hmg/ddm304.
17. Pang J-J, Chang B, Hawes NL, Hurd RE, Davisson MT, et al. (2005) Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA). Molecular vision 11: 152-162. (Pubitemid 41358297)
18. Narfström K, Wrigstad A, Nilsson SE (1989) The Briard dog: a new animal model of congenital stationary night blindness. The British journal of ophthalmology 73: 750-756. (Pubitemid 19236995)
19. Aguirre GD, Baldwin V, Pearce-Kelling S, Narfström K, Ray K, et al. (1998) Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect. Molecular vision 4: 23.
20. Wrigstad A, Narfström K, Nilsson SE (1994) Slowly progressive changes of the retina and retinal pigment epithelium in Briard dogs with hereditary retinal dystrophy. A morphological study. Documenta ophthalmologica Advances in ophthalmology 87: 337-354. (Pubitemid 24339162)
21. Wrigstad A, Nilsson SE, Narfström K (1992) Ultrastructural changes of the retina and the retinal pigment epithelium in Briard dogs with hereditary congenital night blindness and partial day blindness. Experimental eye research 55: 805-818. (Pubitemid 23015854)
22. Beltran WA (2009) The use of canine models of inherited retinal degeneration to test novel therapeutic approaches. Veterinary ophthalmology 12: 192-204. doi:10.1111/j.1463-5224.2009.00694.x.
23. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, et al. (2001) Gene therapy restores vision in a canine model of childhood blindness. Nature genetics 28: 92-95. doi:10.1038/88327. (Pubitemid 32405824)
24. Narfstrom K (2003) Functional and Structural Recovery of the Retina after Gene Therapy in the RPE65 Null Mutation Dog. Investigative Ophthalmology & Visual Science 44: 1663-1672. doi:10.1167/iovs.02-0595.
25. Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, et al. (2007) Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene therapy 14: 292-303. doi:10.1038/sj.gt.3302861. (Pubitemid 46231923)
26. Bennicelli J, Wright JF, Komaromy A, Jacobs JB, Hauck B, et al. (2008) Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Molecular therapy: the journal of the American Society of Gene Therapy 16: 458-465. doi:10.1038/sj.mt.6300389.
27. Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, et al. (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. The New England journal of medicine 358: 2231-2239. doi:10.1056/NEJMoa0802268. (Pubitemid 351724452)
28. Maguire AM, Simonelli F, Pierce EA, Pugh EN, Mingozzi F, et al. (2008) Safety and efficacy of gene transfer for Leber's congenital amaurosis. The New England journal of medicine 358: 2240-2248. doi:10.1056/NEJMoa0802315. (Pubitemid 351724453)
29. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan A V, Schwartz SB, et al. (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Human gene therapy 19: 979-990. doi:10.1089/hum.2008.107.
30. Cideciyan AV, Hauswirth WW, Aleman TS, Kaushal S, Schwartz SB, et al. (2009) Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Human gene therapy 20: 999-1004. doi:10.1089/hum.2009.086.
31. Cideciyan AV (2010) Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Progress in retinal and eye research 29: 398-427. doi:10.1016/j.preteyeres.2010.04.002.
32. Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, et al. (2010) Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Molecular therapy: the journal of the American Society of Gene Therapy 18: 643-650. doi:10.1038/mt.2009.277.
33. Banin E, Bandah-Rozenfeld D, Obolensky A, Cideciyan AV, Aleman TS, et al. (2010) Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel. Human gene therapy 21: 1749-1757. doi:10.1089/hum.2010.047.
34. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, et al. (2012) Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Archives of ophthalmology 130: 9-24. doi:10.1001/archophthalmol.2011.298.
35. Cideciyan AV, Jacobson SG, Beltran WA, Sumaroka A, Swider M, et al. (2013) Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proceedings of the National Academy of Sciences of the United States of America 110: E517-25. doi:10.1073/pnas.1218933110.
36. Ollivier FJ, Samuelson DA, Brooks DE, Lewis PA, Kallberg ME, et al. (2004) Comparative morphology of the tapetum lucidum (among selected species). Veterinary ophthalmology 7: 11-22. (Pubitemid 38251165)
37. Haverkamp S, Wässle H (2000) Immunocytochemical analysis of the mouse retina. The Journal of comparative neurology 424: 1-23. (Pubitemid 30602070)
38. tom Dieck S, Brandstätter JH (2006) Ribbon synapses of the retina. Cell and tissue research 326: 339-346. doi:10.1007/s00441-006-0234-0.
39. Greferath U, Grünert U, Wässle H (1990) Rod bipolar cells in the mammalian retina show protein kinase C-like immunoreactivity. The Journal of comparative neurology 301: 433-442. doi:10.1002/cne.903010308. (Pubitemid 20368504)
40. Michalakis S, Schäferhoff K, Spiwoks-Becker I, Zabouri N, Koch S, et al. (2013) Characterization of neurite outgrowth and ectopic synaptogenesis in response to photoreceptor dysfunction. Cellular and molecular life sciences: CMLS 70: 1831-1847. doi:10.1007/s00018-012-1230-z.
41. Liets LC, Eliasieh K, van der List DA, Chalupa LM (2006) Dendrites of rod bipolar cells sprout in normal aging retina. Proceedings of the National Academy of Sciences of the United States of America 103: 12156-12160. doi:10.1073/pnas.0605211103. (Pubitemid 44215827)
42. Mowat FM, Petersen-Jones SM, Williamson H, Williams DL, Luthert PJ, et al. (2008) Topographical characterization of cone photoreceptors and the area centralis of the canine retina. Molecular vision 14: 2518-2527.
43. Hernández M, Pearce-Kelling SE, Rodriguez FD, Aguirre GD, Vecino E (2010) Altered expression of retinal molecular markers in the canine RPE65 model of Leber congenital amaurosis. Invest Ophthalmoll Vis Sci 51: 6793-6802. doi:10.1167/iovs.10-5213.
44. Eliasieh K, Liets LC, Chalupa LM (2007) Cellular reorganization in the human retina during normal aging. Investigative ophthalmology & visual science 48: 2824-2830. doi:10.1167/iovs.06-1228. (Pubitemid 351261239)
45. Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, et al. (2008) Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proceedings of the National Academy of Sciences of the United States of America 105: 15112-15117. doi:10.1073/pnas. 0807027105.
46. Mowat FM, Breuwer AR, Bartoe JT, Annear MJ, Zhang Z, et al. (2013) RPE65 gene therapy slows cone loss in Rpe65-deficient dogs. Gene therapy 20: 545-555. doi:10.1038/gt.2012.63.
47. Komáromy AM, Rowlan JS, Corr ATP, Reinstein SL, Boye SL, et al. (2013) Transient Photoreceptor Deconstruction by CNTF Enhances rAAV-Mediated Cone Functional Rescue in Late Stage CNGB3-Achromatopsia. Molecular therapy: the journal of the American Society of Gene Therapy 21: 1131-1141. doi:10.1038/mt.2013.50.
48. Strauss O (2005) The retinal pigment epithelium in visual function. Physiological reviews: 845-881. doi:10.1152/physrev.00021.2004.
49. Zhang T, Zhang N, Baehr W, Fu Y (2011) Cone opsin determines the time course of cone photoreceptor degeneration in Leber congenital amaurosis. Proceedings of the National Academy of Sciences of the United States of America 108: 8879-8884. doi:10.1073/pnas.1017127108.